Healthcare
-
Consumers accusing CVS Pharmacy Inc. of overcharging them for generic medications have won a bid to certify classes of drug buyers in New York and Arizona, bringing the total number of certified classes in the case to six… Read this piece in its entirety at Law360.
-
A group of major pharmaceutical companies has agreed to pay a combined $242 million to resolve allegations they bilked Illinois’ government by inflating prices for medicines covered by the state’s Medicaid program, the Prairie State’s attorney general announced Monday… Read this piece in its entirety at Law360.
-
Reckitt Benckiser LLC won’t have to pay attorney fees racked up by generic-drug makers it unsuccessfully sued on claims that they ripped off patents for its Mucinex respiratory relief drug, although a New Jersey federal judge on Friday said the decision on the fees was a “close call”… Read this piece in its entirety at
-
Insurance giant Humana on Friday followed up on a 2018 suit against a slew of generic-drug makers with a new complaint alleging that a swath of additional drugs and companies were involved in a “far-reaching” price-fixing conspiracy at the heart of the earlier case… Read this piece in its entirety at Law360.
-
Actavis Laboratories FL Inc. asked the full Federal Circuit on Wednesday to revisit an August panel decision in a case over weight loss pill patents, citing a partial dissent by one of the panel judges who had argued the decision wrongly created a “new rule” for written description… Read this piece in its entirety at
Mike LaSusa 